← Back to headlines
Zelluna Receives Recommendation to Continue Patient Enrollment in ZIMA-101 Trial
Zelluna has announced that its Independent Data Monitoring Committee has recommended the continuation of patient enrollment in its ZIMA-101 clinical trial.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Dutch Health Agency Warns of Potentially Fatal Trump-Shaped Ecstasy Pills
20m ago
48-Year-Old Anesthesiologist Found Dead in Greek Hospital On-Call Room
2h ago
Art World Mourns Yayoi Kusama as Tributes Highlight Her Lasting Creative Legacy
2h ago
Study Reveals Hidden Arterial Calcification in Young Adults
4h ago